SelectQuote (NYSE:SLQT) President Robert Clay Grant Purchases 79,801 Shares of Stock

SelectQuote, Inc. (NYSE:SLQT) President Robert Grant purchased 79,801 shares of the business’s stock in a transaction that occurred on Friday, November 6th. The stock was acquired at an average cost of $0.51 per share, with a total value of $40,698.51. Following the completion of the acquisition, the president directly owned 3,386,491 shares of the company’s stock, valued at $1,727,110.41. The trade was a 2.41% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

SelectQuote Stock Up 2.6%

Shares of NYSE SLQT opened at $0.46 on Wednesday. The firm’s 50-day simple moving average is $0.42 and its 200 day simple moving average is $0.75. The company has a market cap of $82.36 million, a price-to-earnings ratio of 44.73 and a beta of 2.01. The company has a quick ratio of 7.48, a current ratio of 7.48 and a debt-to-equity ratio of 1.16. SelectQuote, Inc. has a 12-month low of $0.30 and a 12-month high of $1.76.

SelectQuote (NYSE:SLQT) last issued its quarterly earnings data on Wednesday, November 4th. The company reported ($0.21) EPS for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.12. The firm had revenue of $280.01 million for the quarter, compared to analyst estimates of $277.91 million. SelectQuote had a net margin of 4.61% and a return on equity of 22.48%. On average, research analysts expect that SelectQuote, Inc. will post -0.25 earnings per share for the current fiscal year.

Institutional Trading of SelectQuote

Institutional investors have recently bought and sold shares of the business. BlackRock Inc. bought a new stake in shares of SelectQuote during the 2nd quarter valued at $1,836,000. Renaissance Technologies LLC lifted its stake in shares of SelectQuote by 817.6% in the 1st quarter. Renaissance Technologies LLC now owns 1,021,239 shares of the company’s stock valued at $643,000 after purchasing an additional 909,939 shares during the period. GSA Capital Partners LLP acquired a new position in shares of SelectQuote in the 2nd quarter valued at $1,123,000. Hsbc Holdings PLC bought a new position in shares of SelectQuote in the 2nd quarter worth $102,000. Finally, Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of SelectQuote in the 2nd quarter worth $461,000. Institutional investors and hedge funds own 34.59% of the company’s stock.

SelectQuote News Roundup

Here are the key news stories impacting SelectQuote this week:

• Positive Sentiment: Executives and directors bought a combined 919,905 shares for about $447,000 in transactions on November 6 and 9. Purchasers included the CEO, president, COO, and two directors; the largest reported purchase was 409,836 shares by Director Raymond F. Weldon. Broad insider buying may signal confidence, though it does not guarantee improved results. SEC filing SEC filing
• Neutral Sentiment: A report says SelectQuote placed fewer Medicare policies but earned more on each one. Higher per-policy earnings may partly offset weaker policy volume, but the article details provided do not establish the overall effect on revenue or profit. SelectQuote places fewer Medicare policies but earns more on each one

Analyst Upgrades and Downgrades

SLQT has been the topic of several research analyst reports. Wall Street Zen cut shares of SelectQuote from a “hold” rating to a “sell” rating in a research note on Saturday, August 29th. Zacks Research upgraded shares of SelectQuote from a “strong sell” rating to a “hold” rating in a research report on Monday, October 26th. Finally, Weiss Ratings downgraded SelectQuote from a “sell (d+)” rating to a “sell (d)” rating in a report on Monday, August 17th. One analyst has rated the stock with a Strong Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $3.00.

SelectQuote Company Profile

SelectQuote, Inc. (NYSE: SLQT) operates a technology-enabled insurance distribution platform that helps consumers compare and purchase insurance products from third-party carriers. The company combines digital tools, proprietary data and licensed agents to connect customers with coverage suited to their needs. SelectQuote’s primary business is its Senior segment, which provides access to Medicare Advantage, Medicare Supplement and prescription drug plans. The company has also historically offered life insurance, as well as auto and home insurance, through its Life and Auto & Home businesses.